JILLIAN JAROSZEWSKI: Open Payments
NPI 1487051546 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 31 payments from 13 companies in 2025. Trend: 2023 $1,234 · 2024 $1,114 · 2025 $917
Food & beverage: $833Education: $84
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $224 |
| Janssen Biotech, Inc. | 6 | $181 |
| Aimmune Therapeutics, Inc. | 4 | $121 |
| ABBVIE INC. | 4 | $110 |
| Intercept Pharmaceuticals, Inc. | 2 | $52 |
| Madrigal Pharmaceuticals | 1 | $45 |
| QOL Medical, LLC | 1 | $41 |
| Fujifilm Healthcare Americas Corporation | 1 | $35 |
| Ardelyx, Inc. | 1 | $28 |
| ORPHALAN INC | 1 | $23 |
Products named: TREMFYA, ENTYVIO, ZENPEP, LINZESS, GATTEX, OCALIVA, REZDIFFRA, Sucraid.
Industry payments across CT — which companies pay providers there.
